Patents by Inventor Serge Mignani

Serge Mignani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
    Publication number: 20030171369
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Application
    Filed: March 14, 2003
    Publication date: September 11, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Eric Bacque, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michael Evers, Fabrice Viviani, Youssef El Ahmad, Stephane Mutti
  • Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
    Publication number: 20030166646
    Abstract: The present invention relates to the use of 2-amino-thiazoline derivatives of formula (I): 1
    Type: Application
    Filed: November 8, 2002
    Publication date: September 4, 2003
    Inventors: Antony Bigot, Jean-Christophe Carry, Serge Mignani
  • Acetindine derivatives, their preparation and medicaments containing them
    Publication number: 20030162808
    Abstract: Disclosed are azetidine derivatives of formula: 1
    Type: Application
    Filed: December 16, 2002
    Publication date: August 28, 2003
    Inventors: Daniel Achard, Herve Bouchard, Jean Bouquerel, Marc Capet, Serg Grisoni, Jean-Luc Malleron, Serge Mignani, Augustin Hittinger
  • Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase
    Publication number: 20030153605
    Abstract: The present invention relates to the use of 2-amino-4-pyridylmethyl thiazoline derivatives of formula (I) 1
    Type: Application
    Filed: November 8, 2002
    Publication date: August 14, 2003
    Inventors: Eric Bacque, Antony Bigot, Jean-Christophe Carry, Serge Mignani, Baptiste Ronan, Michel Tabart
  • Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
    Patent number: 6603005
    Abstract: Heterocyclylalkylpiperidine derivatives of general formula (I) in their enantiomeric or diastereoisomeric forms or mixtures of these forms, and/or, where appropriate, in their syn or anti form or a mixture thereof, as well as any salt thereof.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: August 5, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Baque, Jean-Christophe Carry, Youssef El-Ahmad, Michel Evers, Philippe Hubert, Jean-Luc Malleron, Serge Mignani, Guy Pantel, Michel Tabart, Fabrice Viviani
  • Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
    Patent number: 6602884
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: August 5, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Bacqué, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michel Evers, Fabrice Viviani, Youssef El Ahmad, Stéphane Mutti, Christophe Daubié
  • Methods of using thiazolobenzoheterocycles
    Publication number: 20030055031
    Abstract: Methods of using compounds of formula (I): 1
    Type: Application
    Filed: July 25, 2002
    Publication date: March 20, 2003
    Applicant: Rhone-Poulenc Rorer S.A.
    Inventors: Jean-Claude Hardy, Jean Bouquerel, Patrick Nemecek, Jean-Claude Aloup, Serge Mignani, Jean-Francois Peyronel
  • Azetidine derivatives, their preparation and medicaments containing them
    Patent number: 6518264
    Abstract: Disclosed are azetidine derivatives of formula: their optical isomers, their salts, their preparation and medicaments containing them.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: February 11, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Hervé Bouchard, Jean Bouquerel, Marc Capet, Serg Grisoni, Jean-Luc Malleron, Serge Mignani, Augustin Hittinger
  • 2-aminothiazoline derivatives and process for preparing the same
    Publication number: 20020198243
    Abstract: The present invention relates to a class of 2-aminothiazoline derivatives of formula I: 1
    Type: Application
    Filed: May 31, 2002
    Publication date: December 26, 2002
    Inventors: Jean-Christophe Carry, Dominique Damour, Claude Guyon, Serge Mignani, Antony Bigot, Eric Bacque, Michel Tabart
  • Use of 2-aminothiazoline derivatives as inhibitors of inducible NO-synthase
    Publication number: 20020187987
    Abstract: The present invention relates to the use of 2-aminothiazoline derivatives of formula I: 1
    Type: Application
    Filed: May 31, 2002
    Publication date: December 12, 2002
    Inventors: Jean-Christophe Carry, Dominique Damour, Claude Guyon, Serge Mignani, Antony Bigot, Eric Bacque, Michel Tabart
  • Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
    Publication number: 20020177606
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Application
    Filed: March 13, 2002
    Publication date: November 28, 2002
    Inventors: Eric Bacque, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michel Evers, Fabrice Viviani, Youssef El Ahmad, Stephane Mutti, Christophe Daubie
  • Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase
    Patent number: 6451821
    Abstract: The present invention relates to the use of 2-aminothiazoline derivatives of formula: in which either R1 is a hydrogen atom or an alkyl radical and R2 is an alkyl, -alk—NH2, —CH2—R3, —CH2—S—R4 or phenyl radical substituted with a nitro or —NH— C (═NH) CH3 radical, or R1 is an alkyl radical and R2 is a hydrogen atom, R3 is a (3-6C) cycloalkyl, pyridyl, pyridyl N-oxide, thienyl, thiazolyl, imidazolyl, pyrazinyl, triazolyl or phenyl radical or a phenyl radical substituted with a nitro, hydroxy or carboxyl radical, R4 represents a pyridyl or pyridyl N-oxide radical, alk represents an alkylene radical, or pharmaceutically acceptable salts thereof, as inhibitors of inducible NO-synthase.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: September 17, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Christophe Carry, Dominique Damour, Claude Guyon, Serge Mignani, Antony Bigot, Eric Bacque, Michel Tabart
  • Thiazolobenzoheterocycles, their preparation and medicaments containing them
    Patent number: 6448241
    Abstract: Compounds of formula (I): their racemates, enantiomers, diastereoisomers and inorganic acid salts and organic acid salts thereof, processes for preparing them and the medicaments containing them are discussed.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: September 10, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Claude Hardy, Jean Bouquerel, Patrick Nemecek, Jean-Claude Aloup, Serge Mignani, Jean-François Peyronel
  • Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
    Publication number: 20020111492
    Abstract: Heterocyclylalkylpiperidine derivatives of general formula (I) 1
    Type: Application
    Filed: November 14, 2001
    Publication date: August 15, 2002
    Inventors: Eric Baque, Jean-Christophe Carry, Youssef El-Ahmad, Michel Evers, Philippe Hubert, Jean-Luc Malleron, Serge Mignani, Guy Pantel, Michel Tabart, Fabrice Viviani
  • Thiazolobenzoheterocycles, their preparation and medicaments containing them
    Patent number: 6423715
    Abstract: Compounds of formula (I): their racemates, enantiomers, diastereoisomers and inorganic acid salts and organic acid salts thereof, processes for preparing them and the medicaments containing them are discussed.
    Type: Grant
    Filed: November 15, 2001
    Date of Patent: July 23, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Claude Hardy, Jean Bouquerel, Patrick Nemecek, Jean-Claude Aloup, Serge Mignani, Jean-François Peyronel
  • Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof
    Patent number: 6420566
    Abstract: The present invention relates to pharmaceutical compositions containing, as active principle, a 4,5-dihydro-1,3-thiazol-2-ylamine derivative of formula (I): in which R represents an -alk-S-alk-Ar radical, a phenyl radical or a phenyl radical substituted with alkoxy or halogen, or to one of the pharmaceutically acceptable salts thereof, to the novel derivatives of formula (I) and to their preparation.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: July 16, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Christophe Carry, Dominique Damour, Claude Guyon, Serge Mignani, Eric Bacque, Antony Bigot
  • Polyhydroxyalkylpyrazine derivatives and their preparation and medicines containing them
    Patent number: 6407110
    Abstract: The invention concerns medicines containing as active principle at least a compound of formula (I): wherein either R2 represents a —CH2—(CHOH)2—CH3 chain and R3 represents a hydrogen atom or R2 represents a hydrogen atom and R3 represents a —CH2—(CHOH)2—CH3 chain or one of its stereoisomers or one of its salts, the novel compounds of formula (I), their stereoisomers, their salts and their preparation.
    Type: Grant
    Filed: January 11, 2001
    Date of Patent: June 18, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Georges Bashiardes, Jean-Christophe Carry, Michel Evers, Bruno Filoche, Serge Mignani
  • Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
    Patent number: 6403610
    Abstract: Quinolylpropylpiperidine derivatives of formula (I) which are particularly advantageous antimicrobial agents, their compositions, and their use.
    Type: Grant
    Filed: September 18, 2000
    Date of Patent: June 11, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Luc Malleron, Michel Tabart, Jean-Christophe Carry, Michel Evers, Youssef El Ahmad, Serge Mignani, Fabrice Viviani, Michel Cheve
  • Pyrazine derivatives, their preparation and medicaments containing them
    Patent number: 6399613
    Abstract: The invention concerns pyrazine derivatives of formula (1) in which a pharmaceutical composition comprising at least one compound of formula: in which R represents a nitrogen atom, R1 and R3 each represent the same radical selected from the group consisting of —CO—NR5R6, —CO—N(CH(CH2OH)2)2, —CO—N(CH2OH)2, —CO—N(CH2—CH(CH2OH)2)2, —CO—N(CH2—(CHOH)n—CH2OH)2 in which n is equal to 0, 1, 2, 3 or 4, —CH2—O—R6, —NR5—CO—R6, —CH2—NR5R6, —CH2—N(CH2OH)2, —CH2—N(CH2—(CHOH)y—CH2OH)2 in which y is equal to 0, 1, 2, 3 or 4, —CH2—N(CH(CH2OH)2)2 and —CH2—N(CH2—CH(CH2OH)2)2 and R2 and R4 each represents a hydrogen atom, R5 represents a hydrogen atom or an alkyl radical, R6 represents a radical —CH2—(CHOH)m—CH2OH in which m is equal to 0, 1, 2, 3 or 4, -alk-O-alk-CH2OH, -alk-O-alk, —CH(CH2OH)2,
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: June 4, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Georges Bashiardes, Jean-Christophe Carry, Michel Evers, Bruno Filoche, Serge Mignani
  • Polyhydroxyalkylpyrazine derivatives, their preparation and medicaments comprising them
    Patent number: 6392042
    Abstract: A pharmaceutical composition containing at least one stereoisomer of at least one compound selected from: Or a salt thereof with an organic or inorganic acid.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: May 21, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Georges Bashiardes, Jean-Christophe Carry, Michel Evers, Bruno Filoche, Serge Mignani